ES2043631T3 - Procedimiento de preparacion de hidroxialquilxantinas. - Google Patents

Procedimiento de preparacion de hidroxialquilxantinas.

Info

Publication number
ES2043631T3
ES2043631T3 ES87115591T ES87115591T ES2043631T3 ES 2043631 T3 ES2043631 T3 ES 2043631T3 ES 87115591 T ES87115591 T ES 87115591T ES 87115591 T ES87115591 T ES 87115591T ES 2043631 T3 ES2043631 T3 ES 2043631T3
Authority
ES
Spain
Prior art keywords
hydroxial
alkylxantines
preparation procedure
compound
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87115591T
Other languages
English (en)
Spanish (es)
Inventor
Rene Fumeaux
Georges Philipposian
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2043631T3 publication Critical patent/ES2043631T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES87115591T 1986-10-27 1987-10-23 Procedimiento de preparacion de hidroxialquilxantinas. Expired - Lifetime ES2043631T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4253/86A CH670090A5 (US07786301-20100831-C00010.png) 1986-10-27 1986-10-27

Publications (1)

Publication Number Publication Date
ES2043631T3 true ES2043631T3 (es) 1994-01-01

Family

ID=4272668

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87115591T Expired - Lifetime ES2043631T3 (es) 1986-10-27 1987-10-23 Procedimiento de preparacion de hidroxialquilxantinas.

Country Status (13)

Country Link
EP (1) EP0269841B1 (US07786301-20100831-C00010.png)
JP (1) JP2527769B2 (US07786301-20100831-C00010.png)
KR (1) KR930010559B1 (US07786301-20100831-C00010.png)
AT (1) ATE82289T1 (US07786301-20100831-C00010.png)
AU (1) AU604767B2 (US07786301-20100831-C00010.png)
CA (1) CA1296001C (US07786301-20100831-C00010.png)
CH (1) CH670090A5 (US07786301-20100831-C00010.png)
DE (1) DE3782619T2 (US07786301-20100831-C00010.png)
DK (1) DK169336B1 (US07786301-20100831-C00010.png)
ES (1) ES2043631T3 (US07786301-20100831-C00010.png)
GR (1) GR3006223T3 (US07786301-20100831-C00010.png)
IL (1) IL84266A (US07786301-20100831-C00010.png)
ZA (1) ZA877851B (US07786301-20100831-C00010.png)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
DE4316576A1 (de) * 1993-05-18 1994-11-24 Boehringer Ingelheim Kg Verbessertes Verfahren zur Herstellung von 1,3-Dipropyl-8-(3-Oxocyclopentyl)-xanthin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
FR1211333A (fr) * 1955-10-19 1960-03-15 Boehringer Sohn Ingelheim Perfectionnements apportés aux procédés pour fabriquer des oxyalcoylxanthines
US4567183A (en) * 1983-03-11 1986-01-28 Analgesic Associates Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same
US4558051A (en) * 1983-10-11 1985-12-10 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising xanthines and methods of using same

Also Published As

Publication number Publication date
ATE82289T1 (de) 1992-11-15
IL84266A0 (en) 1988-03-31
DK169336B1 (da) 1994-10-10
ZA877851B (en) 1988-04-22
EP0269841A1 (fr) 1988-06-08
GR3006223T3 (US07786301-20100831-C00010.png) 1993-06-21
EP0269841B1 (fr) 1992-11-11
DE3782619D1 (de) 1992-12-17
AU604767B2 (en) 1991-01-03
CA1296001C (en) 1992-02-18
KR930010559B1 (ko) 1993-10-28
CH670090A5 (US07786301-20100831-C00010.png) 1989-05-12
AU7998087A (en) 1988-04-28
JP2527769B2 (ja) 1996-08-28
IL84266A (en) 1992-02-16
DK551487D0 (da) 1987-10-21
KR880005131A (ko) 1988-06-28
DE3782619T2 (de) 1993-04-22
JPS63122683A (ja) 1988-05-26
DK551487A (da) 1988-04-28

Similar Documents

Publication Publication Date Title
DE3372707D1 (en) Spiro-(4,(3+n))-2-aza-alkan-3-carboxylic-acid derivatives, process for their preparation,agents containing them and their use
AU557691B2 (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
JPS5513278A (en) Benzomorphane compound and medical compound containing it
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
ES514267A0 (es) "un procedimiento para la preparacion de derivados de pirrolidina".
ZA872683B (en) 1,5-benzothiazepine derivatives,their preparation and compositions containing them
DK373783A (da) Thieno-thiazol-derivater, fremgangsmaade til deres fremstilling samt deres anvendelse
ES2043631T3 (es) Procedimiento de preparacion de hidroxialquilxantinas.
IL73042A0 (en) Hydroxyethylazolyl-oxime derivatives,their preparation and their use as fungicides
GR3007219T3 (US07786301-20100831-C00010.png)
DK364386A (da) 1-alkyl-ergolinyl-thiourinstofderivater og fremgangsmaade til fremstilling deraf samt deres anvendelse
PT72340B (en) Process for the preparation of a fungicidal composition containing esters of indan-4-yl of n-alkyl-carbamic acids
DE3885978T2 (de) Cephemverbindungen und Verfahren zu ihrer Herstellung.
IL78748A (en) Phosphorimidates,their preparation and their use as pesticides
GB2014849A (en) Compositions containing an anti- depressant and a tranquiliser

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 269841

Country of ref document: ES